J. Utsumi

What is the benefit of aggressive chemotherapy for advanced neuroblastoma with N-myc amplification? A report from the Japanese Study Group for the Treatment of Advanced Neuroblastoma.

K. Kawa, S. Suita, M. Kaneko, 1994, Journal of Pediatric Surgery.

Comparison of intermittent or continuous methotrexate plus 6‐mercaptopurine in regimens for standard‐risk acute lymphoblastic leukemia in childhood (JCCLSG‐S811)

J. Mimaya, T. Takeda, S. Koizumi, 1988, Cancer.

Familial Leukemia: HLA System and Leukemia Predisposition in a Family

Y. Tsunematsu, R. Koide, K. Tsuji, 1983 .

Primary familial polycythaemia associated with a novel point mutation in the erythropoietin receptor

K. Kishi, Y. Aizawa, M. Masuko, 1997, British journal of haematology.

Evaluation of patients with advanced neuroblastoma surviving more than 5 years after initiation of an intensive Japanese protocol: a report from the Study Group of Japan for Treatment of Advanced Neuroblastoma.

M. Fukuzawa, S. Suita, H. Mugishima, 1996, Medical and pediatric oncology.

Fatal Progressive Meningoencephalitis Diagnosed in Two Members of a Family With X-Linked Agammaglobulinemia

H. Kanegane, A. Kakita, H. Shimizu, 2020, Frontiers in Pediatrics.

Site-directed chromosome rearrangements in skin fibroblasts from persons carrying genes for hereditary neoplasms.

Y. Tsunematsu, J. Utsunomiya, M. Sasaki, 1980, Cancer research.

Successful treatment of retinoic acid syndrome with high‐dose dexamethasone pulse therapy in a child with acute promyelocytic leukemia treated with ATRA

Y. Sasazaki, K. Asami, J. Utsumi, 1995, Acta paediatrica Japonica : Overseas edition.